- Home
- ADAP vs XNET Comparison
ADAP vs XNET Comparison
Compare ADAP & XNET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAP
- XNET
- Stock Information
- Founded
- ADAP 2008
- XNET 2003
- Country
- ADAP United Kingdom
- XNET China
- Employees
- ADAP N/A
- XNET N/A
- Industry
- ADAP Biotechnology: Pharmaceutical Preparations
- XNET Computer Software: Prepackaged Software
- Sector
- ADAP Health Care
- XNET Technology
- Exchange
- ADAP Nasdaq
- XNET Nasdaq
- Market Cap
- ADAP 158.6M
- XNET 131.8M
- IPO Year
- ADAP 2015
- XNET 2014
- Fundamental
- Price
- ADAP $0.58
- XNET $2.12
- Analyst Decision
- ADAP Strong Buy
- XNET
- Analyst Count
- ADAP 4
- XNET 0
- Target Price
- ADAP $2.79
- XNET N/A
- AVG Volume (30 Days)
- ADAP 2.3M
- XNET 111.5K
- Earning Date
- ADAP 03-05-2025
- XNET 03-13-2025
- Dividend Yield
- ADAP N/A
- XNET N/A
- EPS Growth
- ADAP N/A
- XNET 146.84
- EPS
- ADAP N/A
- XNET 0.23
- Revenue
- ADAP $175,041,000.00
- XNET $359,611,000.00
- Revenue This Year
- ADAP $204.91
- XNET N/A
- Revenue Next Year
- ADAP N/A
- XNET N/A
- P/E Ratio
- ADAP N/A
- XNET $9.37
- Revenue Growth
- ADAP 146.27
- XNET 99.13
- 52 Week Low
- ADAP $0.53
- XNET $1.45
- 52 Week High
- ADAP $2.05
- XNET $2.41
- Technical
- Relative Strength Index (RSI)
- ADAP 41.87
- XNET 54.45
- Support Level
- ADAP $0.55
- XNET $1.99
- Resistance Level
- ADAP $0.65
- XNET $2.17
- Average True Range (ATR)
- ADAP 0.05
- XNET 0.10
- MACD
- ADAP 0.00
- XNET 0.00
- Stochastic Oscillator
- ADAP 31.31
- XNET 83.02
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70 and others for multiple cancer types.
About XNET Xunlei Limited
Xunlei Ltd is a cloud-based acceleration technology company in China. The company operates a powerful internet platform in China based on cloud computing to provide users with quick and easy access to digital media content through its products and services, Xunlei Accelerator, and cloud acceleration subscription services. It is increasingly extending into mobile devices in part through potentially pre-installed acceleration products in mobile phones Xunlei has developed various value-added services to meet a fuller spectrum of its users' digital media content access and consumption needs.